Skip to main content

Table 1 Percentage weekly change in pain severity among patients with painful DPN or PHN receiving treatment with pregabalin or gabapentin

From: Pregabalin versus gabapentin in the management of peripheral neuropathic pain associated with post-herpetic neuralgia and diabetic neuropathy: a cost effectiveness analysis for the Greek healthcare setting

 

Pregabalin n = 141

Gabapentin n = 193

Mean dose mg/day

457

2400

Mean total weekly reduction versus baseline in daily pain scores %

Week 1

13.7

17.2

Week 2

23.2

25.1

Week 3

29.9

29.7

Week 4

39.1

32.1

Week 5

44.4

33.7

Week 6

44.2

34.9

Week 7

45.0

35.8

Week 8

46.3

36.4

Week 9

49.8

36.9

Week 10

51.1

37.2

Week 11

53.3

37.4

Week 12

54.1

37.6

  1. Data obtained from Protocol 1008–155 for pregabalin [7], and Protocols 945–210 and 945–211 for gabapentin [9, 10].